National Cancer Institute - Alliance for Nanotechnology in Cancer
U.S. National Institutes of Health | nano.cancer.gov
 
 
National Cancer Institute NCI Alliance for Nanotechnology in Cancer
Nanotechnology:
Critical Endeavor
in Cancer

>  Why Nanotechnology?
>  Nanowires
>  Cantilevers
>  Nanoshells
>  Nanoparticles

Nanotechnology
Centers of Excellence
>  Mission
Multidisciplinary
Research Teams
>  Mission
Nanotechnology
Platforms for Cancer
Research
>  Mission
Nanotechnology
Characterization
Lab (NCL)
>  Mission

Nanotech Highlights

Career Opportunity
Cancer Nanotechnology Program Manager
Closing Date: October 29, 2004
[Full Job Description]

NCAB Meeting
Tuesday, September 14, 2004
Mini-Symposium:
The Science of Nanotechnology
10:45am - 12:30pm
[Program Agenda]
[Speaker Bios]

Alliance Launch Day
Monday, September 13, 2004
Natcher Conference Center
NIH Bethesda, Maryland


Going Small For
Big Advances

Cancer Nanotechnology Brochure


Download This Brochure To
Learn More


Director's Statement

Message From The Director

Nanotechnology: Critical Endeavor in Cancer
Why Nanotechnology in Cancer - Nanowires - Cantilevers - Nanoshells - Nanoparticles

Nanotechnology: Critical Endeavor in Cancer


Reference: Ed Neuwelt, Oregon Health Sciences University


Replay Animation


Previous Animation

Nanoparticles

Nanoscale devices have the potential to radically change cancer therapy for the better and to dramatically increase the number of highly effective therapeutic agents.

In this example, nanoparticles are targeted to cancer cells for use in the molecular imaging of a malignant lesion. Large numbers of nanoparticles are safely injected into the body and preferentially bind to the cancer cell, defining the anatomical contour of the lesion and making it visible.

These nanoparticles give us the ability to see cells and molecules that we otherwise cannot detect through conventional imaging. The ability to pick up what happens in the cell — to monitor therapeutic intervention and to see when a cancer cell is mortally wounded or is actually activated — is critical to the successful diagnosis and treatment of the disease.

Nanoparticulate technology can prove to be very useful in cancer therapy allowing for effective and targeted drug delivery by overcoming the many biological, biophysical and biomedical barriers that the body stages against a standard intervention such as the administration of drugs or contrast agents.

Reference Scientific Bibliography:
   Nanotechnology - Enabled Therapeutics Development and Delivery

 

   



A Service of the National Cancer Institute
Department of Health and Human ServicesNational Institutes of HealthFirstGov.gov